首页> 外文期刊>BMC Cancer >Characterization of MicroRNA-200 pathway in ovarian cancer and serous intraepithelial carcinoma of fallopian tube
【24h】

Characterization of MicroRNA-200 pathway in ovarian cancer and serous intraepithelial carcinoma of fallopian tube

机译:输卵管卵巢癌和浆液性上皮内癌的MicroRNA-200通路的表征

获取原文
获取外文期刊封面目录资料

摘要

Background Ovarian cancer is the leading cause of death among gynecologic diseases in Western countries. We have previously identified a miR-200-E-cadherin axis that plays an important role in ovarian inclusion cyst formation and tumor invasion. The purpose of this study was to determine if the miR-200 pathway is involved in the early stages of ovarian cancer pathogenesis by studying the expression levels of the pathway components in a panel of clinical ovarian tissues, and fallopian tube tissues harboring serous tubal intraepithelial carcinomas (STICs), a suggested precursor lesion for high-grade serous tumors. Methods RNA prepared from ovarian and fallopian tube epithelial and stromal fibroblasts was subjected to quantitative real-time reverse-transcription polymerase chain reaction (qRT-PCR) to determine the expression of miR-200 families, target and effector genes and analyzed for clinical association. The effects of exogenous miR-200 on marker expression in normal cells were determined by qRT-PCR and fluorescence imaging after transfection of miR-200 precursors. Results Ovarian epithelial tumor cells showed concurrent up-regulation of miR-200, down-regulation of the four target genes ( ZEB1, ZEB2, TGFβ1 and TGFβ2 ), and up-regulation of effector genes that were negatively regulated by the target genes. STIC tumor cells showed a similar trend of expression patterns, although the effects did not reach significance because of small sample sizes. Transfection of synthetic miR-200 precursors into normal ovarian surface epithelial (OSE) and fallopian tube epithelial (FTE) cells confirmed reduced expression of the target genes and elevated levels of the effector genes CDH1, CRB3 and EpCAM in both normal OSE and FTE cells. However, only FTE cells had a specific induction of CA125 after miR-200 precursor transfection. Conclusions The activation of the miR-200 pathway may be an early event that renders the OSE and FTE cells more susceptible to oncogenic mutations and histologic differentiation. As high-grade serous ovarian carcinomas (HGSOC) usually express high levels of CA125, the induction of CA125 expression in FTE cells by miR-200 precursor transfection is consistent with the notion that HGSOC has an origin in the distal fallopian tube.
机译:背景技术在西方国家,卵巢癌是导致妇科疾病死亡的主要原因。我们以前已经确定了miR-200-E-钙粘着蛋白轴在卵巢包涵体囊肿形成和肿瘤侵袭中起重要作用。这项研究的目的是通过研究一系列临床卵巢组织和具有浆液性输卵管上皮内癌的输卵管组织中途径成分的表达水平,确定miR-200途径是否参与卵巢癌发病的早期阶段。 (STICs),这是一种针对高度浆液性肿瘤的建议前体病变。方法对卵巢,输卵管上皮和基质成纤维细胞中提取的RNA进行实时定量逆转录聚合酶链反应(qRT-PCR),以确定miR-200家族,靶标和效应基因的表达,并分析其临床关联性。转染miR-200前体后,通过qRT-PCR和荧​​光成像确定外源性miR-200对正常细胞中标志物表达的影响。结果卵巢上皮肿瘤细胞同时表达miR-200、4个靶基因(ZEB1,ZEB2,TGFβ1和TGFβ2)下调,以及被该靶基因负调控的效应基因上调。 STIC肿瘤细胞表现出相似的表达模式趋势,尽管由于样本量小,其影响并未达到显着水平。将合成的miR-200前体转染到正常卵巢表面上皮(OSE)和输卵管上皮(FTE)细胞中,证实了正常OSE和FTE细胞中靶基因的表达降低,而效应基因CDH1,CRB3和EpCAM的水平升高。但是,在miR-200前体转染后,只有FTE细胞具有CA125的特异性诱导。结论miR-200途径的激活可能是一个早期事件,使OSE和FTE细胞更容易受到致癌突变和组织学分化的影响。由于高级浆液性卵巢癌(HGSOC)通常表达高水平的CA125,因此miR-200前体转染在FTE细胞中诱导CA125表达与HGSOC起源于输卵管远端的观点一致。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号